Hints and tips:
...Priority diseases are receiving more R&D spending and there are more drugs in the pipeline. Initiatives to help patients obtain treatment in poorer countries are also increasing....
...“what concerns me is that i know he’ll never tell us when at risk,” Mr Gardiner replied....
...Lindsay Gardiner, leader of the subsidies project at the OFT, said the change would mean not only that inefficient aid was blocked but that smaller, potentially useful, aid was granted more quickly than...
International Edition